Apogee Therapeutics, Inc.
SEC CIK 1974640 · APGE · last insider filing 2026-06-24
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Henderson Michael Thomas | Director · Chief Executive Officer | filed 2023 - 2026 |
| Jones William A JR | Director | filed 2023 - 2026 |
| Shah Nimish P | Director | filed 2023 - 2026 |
| Mckenna Mark C. | Director | filed 2023 - 2026 |
| Fairmount Funds Management LLC | Director | filed 2023 - 2026 |
| Kiselak Tomas | Director | filed 2023 - 2026 |
| Fox Jennifer A. | Director | filed 2023 - 2026 |
| Bollinger Lisa | Director | filed 2024 - 2026 |
| Harwin Peter Evan | Director | filed 2023 - 2026 |
| Fairmount Healthcare Fund II L.P. | Director | filed 2023 - 2026 |
| Gottesdiener Andrew | Director | filed 2023 - 2025 |
| Fairmount Healthcare Fund L.P. | Director | filed 2023 - 2024 |
| Fairmount Healthcare Co-Invest II L.P. | Director | filed 2023 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Dambkowski Carl | Chief Medical Officer | filed 2023 - 2026 |
| Henderson Jane | Chief Financial Officer | filed 2023 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.